BioStock

Prenumeration

Phase Holographic: BioStock: Shift to regenerative medicine increases growth prospects for PHI

2024-03-20 08:53:12

With a sharp focus on expanding its market to regenerative medicine, medtech company PHI has a growth trajectory that is on a notable upward trend, marked by its highest-ever sales performances in the last quarter. BioStock talked to the company CEO, Patrik Eschricht, for an operational overview and to learn about the behind-the-scenes developments right now.

Read the full interview with Patrik Eschricht at biostock.se:

https://www.biostock.se/en/2024/03/shift-to-regenerative-medicine-increases-growth-prospects-for-phi/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

BioStock

Prenumeration

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden